Improved response with post-ASCT consolidation by low dose thalidomide, cyclophosphamide and dexamethasone as first line treatment for multiple myeloma-Reference-Cited by-同舟云学术

Improved response with post-ASCT consolidation by low dose thalidomide, cyclophosphamide and dexamethasone as first line treatment for multiple myeloma

Published:2012-06-19 Issue:4 Volume:158 Page:499-505
ISSN:0007-1048
Container-title:British Journal of Haematology
language:en
Short-container-title:Br J Haematol

Author:

Rabin Neil¹,Percy Laura²,Khan Iftekhar³,Quinn John²,D'Sa Shirley¹,Yong Kwee L.²

Affiliation:

1. Department of Haematology; University College London Hospitals NHS Foundation Trust; London; UK

2. Academic Department of Haematology; University College London; London; UK

3. Cancer Research UK and UCL Cancer Trials Centre, University College London; London; UK

Publisher

Wiley

Subject

Hematology

Link

http://onlinelibrary.wiley.com/wol1/doi/10.1111/j.1365-2141.2012.09188.x/fullpdf

Reference28 articles.

1. Single versus double autologous stem-cell transplantation for multiple myeloma;Attal;New England Journal of Medicine,2003

2. Maintenance therapy with thalidomide improves survival in patients with multiple myeloma;Attal;Blood,2006

3. Maintenance treatment with lenalidomide after transplantation for myeloma: analysis of secondary malignanciesd with the IFM 2005-02 trial;Attal;Haematologica,2011

4. Thalidomide arm of Total Therapy 2 improves complete remission duration and survival in myeloma patients with metaphase cytogenetic abnormalities;Barlogie;Blood,2008a

5. Duration of survival in patients with myeloma treated with thalidomide;Barlogie;New England Journal of Medicine,2008b

Cited by 7 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Augmenting Autologous Stem Cell Transplantation to Improve Outcomes in Myeloma;Biology of Blood and Marrow Transplantation;2016-11

2. Antitumor efficacy of lidamycin against human multiple myeloma RPMI 8226 cells and the xenograft in nonobese diabetic/severe combined immunodeficiency mice;Journal of Cancer Research and Therapeutics;2016

3. The Choice of Multiple Myeloma Induction Therapy Affects the Frequency and Severity of Oral Mucositis After Melphalan-Based Autologous Stem Cell Transplantation;Clinical Lymphoma Myeloma and Leukemia;2014-08

4. United Kingdom Myeloma Forum position statement on the use of consolidation and maintenance treatment in myeloma;International Journal of Laboratory Hematology;2014-03-27

5. Current strategies for treatment of relapsed/refractory multiple myeloma;Expert Review of Hematology;2014-01-29